Venous access is the most common invasive medical procedure and the success rate is unacceptably low: Only about 75% of all venipunctures are successful at the first attempt, often three or more attempts are necessary.
Excagol aims to reduce the failure rate from 25% at the first attempt in the manual process to 5% in the automated process.